Results 301 to 310 of about 304,424 (378)
Clinical Management of Postoperative Growth Hormone Deficiency in Hypothalamic-Pituitary Tumors. [PDF]
Iglesias P.
europepmc +1 more source
Utilities Associated with the Treatment of Growth Hormone Deficiency (GHD): A Time Trade-off (TTO) Study in the UK and Canada. [PDF]
Kirsch S+5 more
europepmc +1 more source
Altered individual-level morphological similarity network in children with growth hormone deficiency. [PDF]
Cheng Y+11 more
europepmc +1 more source
Isolated Growth Hormone Deficiency IA due to a Novel Homozygous Large Deletion ∼1.6 kb Spanning Exons 1-4 of GH1 Gene: A Case Report. [PDF]
Noorian S+4 more
europepmc +1 more source
This article mainly introduces the pathologic process of sarcopenia and the recent progress in diagnosis and treatment, especially the nondrug treatment. ABSTRACT Sarcopenia refers to the progressive decline and wasting of skeletal muscle function, typically linked to aging or as a secondary effect of various conditions, including systemic inflammation,
Qi‐Fei Kuang+2 more
wiley +1 more source
High-coverage targeted lipidomics revealed a novel serum lipid dysregulation profile in adult growth hormone deficiency. [PDF]
Yang H+7 more
europepmc +1 more source
The body component score (BCS) consists of three key elements: skeletal muscle, bodily fat, and ectopic fat. BCS can comprehensively represent the states of body composition and predict the long‐term survival of resectable colorectal cancer following radical resection.
Takashi Aida+9 more
wiley +1 more source
The clinical and genetic aspects of six individuals with GH1 variants and isolated growth hormone deficiency type II. [PDF]
Huang X+6 more
europepmc +1 more source